Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Medinova Diagnostic Services

526301
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Medinova Diagnostic Services Share price and Fundamental Analysis

View All Details
View All Details
Medinova Diagnostic Services Ltd (MDSL), incorporated in Mar.'93, commenced business on 26 Mar.'93. It belongs to Standard Organics group. The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology.
Company Incorporation1993
ChairmanSura Surendranath Reddy
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
40.58
PE Ratio
19
Industry P/E
45.8
PEG Ratio
7.68
ROE
-151.99%
ROCE
79.86%
ROA
30.88%
Total Debt (Cr)
5
Debt to Equity
-4.01
Dividend Yield
0%
EPS
2.14
Book Value & P/B
-1.23 x 0
Face Value
10
Outstanding Shares(Cr)
1
Current Ratio
1.41
EV to Sales
4.35

Stock Returns

1 Week-1.81%
1 Month-5.47%
6 Months+10.46%
1 Year+5.28%
3 Years+65.92%
5 Years+182.29%
no_data

No Stocks

Smart Score

2.6
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone
PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 62.14%

FIIs : 0.00%

DIIs : 0.00%

Public : 37.86%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Medinova Diagnostic Services Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Medinova Diagnostic Services Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Medinova Diagnostic Services Ltd (MDSL), incorporated in Mar.'93, commenced business on 26 Mar.'93. It belongs to Standard Organics group. The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations, radiology & imaging, conventional, specialized lab services and diagnostic cardiology.

MDSL has acquired the business and undertaking of the diagnostic services division of Standard Medical & Pharmaceuticals (SMPL) as a going concern together with assets and liabilities from 1 Apr.'93. It has four main diagnostic centres in Hyderabad, Bangalore, Pune, and Kolkata apart from mini/medium-sized franchise centres at Karimnagar, Mancherial, Vizag, Nellore.

MDSL came out with a public issue of 67.50 lac equity shares at par, aggregating Rs 6.75 cr, in Nov.'93. The company has installed three magnetic resonance imaging units and other equipment with the latest technology in diagnostic centres in Hyderabad and Bangalore, at a capital outlay of Rs 10 cr.

MDSL has completed a consultancy assignment for an overseas project in Abuja, Nigeria, earning valuable foreign exchange. A new CT machine was installed in Hyderabad in Feb.'95.

In the year 1996-97 the company Medinova- Hyderabad has achieved the ISO 9002 Certification. With this the Company was the first to obtain ISO 9002 certification in the field of medical diagnostics. The company has opened a medium sized Centre at Pimpri (Pune) as a part of its expansion plan.

During 1998-99, The Company installed a Magnetic Resonance Imaging Unit (MRI) and the latest model of Auto Analyser Hitachi 902 at the Hyderabad Unit and a Color Doppler SONOS 2500 supplied by M/s Hewlett Packard has been installed at Kolkata Centre.

A new CT scan machines was installed at Pune and Kolkata and a Cardiac equipment at Bangalore was also installed. A new and innonvative health schemes has to be flagged off to increase the revenues for the company.

A new Cell Counter Machine for Haematology Department was installed in 2005; new Auto Analyser for Biochemistry Department was installed during 2006 at Kolkata centre; new Ultrasound Machine got installed in 2007 at Kolkata centre. In 2008, it installed new Auto Analyzer, Cell Counter and Semi Auto Analyzer machines at Pune and Hyderabad Centres. Equipments like Ultrasound, System, Digital Color Doppler and X Ray were acquired in 2009. Further, equipments such as Computed Radiography System and Semi Auto Analyzers got launched to upgrade the centres in 2010. Colour Droppler, Ultra Sound and Stress Test Machines were acquired in 2011. The Centres got upgraded by acquiring new CT Machine, Digital X-ray & Ultrasound Scanners in 2012.

During the year 2014, Bangalore Unit of the Company was sold/transferred as-a-going-concern, on slump sale basis together with all its assets and liabilities, to M/s. Mallya Hospital (Purchaser) for a total consideration of Rs.715 lakhs, through which the transaction got completed and the sale became effective from January 31, 2014. Post sale of the Bangalore unit, the Company's retained business include the diagnostic service centres at Hyderabad, Pune, Kolkata and a mini centre at Bansdroni (Kolkata). Similarly, in 2014, M/s. Vijaya Diagnostic Centre Private Limited acquired 24.54% shares of the Company equivalent to 29.01% (29.16% of Voting Capital of MDSL) shareholding from the erstwhile Promoter M/s. Standard Medical & Pharmaceuticals Limited and made open offer for additional 26% of the Equity Shares. Consequently, M/s. Vijaya Diagnostic Centre Private Limited after completion of the open offer and acquisition of shares acquired the Management Control and became the Promoter of the Company.

Medinova Diagnostic Services Share Price

Medinova Diagnostic Services share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Medinova Diagnostic Services Market Cap

Market capitalization of Medinova Diagnostic Services indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Medinova Diagnostic Services is valued compared to its competitors.

Medinova Diagnostic Services PE Ratio

Medinova Diagnostic Services PE ratio helps investors understand what is the market value of each stock compared to Medinova Diagnostic Services 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Medinova Diagnostic Services PEG Ratio

The PEG ratio of Medinova Diagnostic Services evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Medinova Diagnostic Services ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Medinova Diagnostic Services generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Medinova Diagnostic Services ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Medinova Diagnostic Services in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Medinova Diagnostic Services Total Debt

Total debt of Medinova Diagnostic Services shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Medinova Diagnostic Services Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Medinova Diagnostic Services compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Medinova Diagnostic Services CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Medinova Diagnostic Services over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Medinova Diagnostic Services Technical Analysis

Technical analysis of Medinova Diagnostic Services helps investors get an insight into when they can enter or exit the stock. Key components of Medinova Diagnostic Services Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Medinova Diagnostic Services shares often struggle to rise above due to selling pressure.

Medinova Diagnostic Services Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Medinova Diagnostic Services ’s financial health and profitability.

Medinova Diagnostic Services Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Medinova Diagnostic Services Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Medinova Diagnostic Services Financials

The financials of Medinova Diagnostic Services provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Medinova Diagnostic Services Profit and Loss Statements

The profit and loss statement of Medinova Diagnostic Services highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Medinova Diagnostic Services .

Medinova Diagnostic Services Balance Sheet

The balance sheet presents a snapshot of Medinova Diagnostic Services ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Medinova Diagnostic Services Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.